FDA Amends Regulations to Clarify Review of Scientific Controversies by Advisory Panels and Committees

Summary

The Food and Drug Administration (FDA) is updating its regulations to provide clarity on the review process for scientific controversies related to drug and device approvals, allowing applicants to request review by a scientific advisory panel or committee, if applicable.